A joint congress of perfusiologists from ROSECT and RosECMO was held against the backdrop of the beautifully decorated stained glass windows of the first-class ParkLine complex on Krestovsky Island (St. Petersburg). The unique specialists attending this event are responsible for artificial blood circulation in their daily work, provide perfusion and protection of the myocardium during operations in cardiac surgery departments, and save patients with urgent heart pathology.
The manufacturer of the drug Normacor acted as the official sponsor of the event, presented new instructions, updated polymer packaging, and improved shelf life.
The new Normacor cardioplegia dosing regimen, which has proven its effectiveness in a clinical trial, is able to provide a bloodless surgical field for the most complex cardiac surgical procedures with a duration of 1.5 - 2 hours of aortic compression. The advantages of the Normacor cardioplegic solution allow the cardiac surgeon to focus on high-quality surgery techniques, reduce the time of artificial blood circulation and, at the end of the operation, obtain spontaneous restoration of the heart rhythm.
